PL2316530T3 - Triglicerydy, kwasy tłuszczowe i alkohole jako modulatory oun - Google Patents

Triglicerydy, kwasy tłuszczowe i alkohole jako modulatory oun

Info

Publication number: PL2316530T3
Authority: PL; Poland
Prior art keywords: triglycerides; alcohols; fatty acids; cns modulators; cns
Prior art date: 2004-05-12

Application number

PL10184846T

Other languages

English (en)

Inventor

Wilfred Dimpfel

David Greenwood

Original Assignee

Btg Int Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-05-12

Filing date

2005-05-12

Publication date

2015-01-30

2005-05-12 Application filed by Btg Int Ltd filed Critical Btg Int Ltd

2015-01-30 Publication of PL2316530T3 publication Critical patent/PL2316530T3/pl

Links

150000001298 alcohols Chemical class 0.000 title 1
235000014113 dietary fatty acids Nutrition 0.000 title 1
229930195729 fatty acid Natural products 0.000 title 1
239000000194 fatty acid Substances 0.000 title 1
150000004665 fatty acids Chemical class 0.000 title 1
150000003626 triacylglycerols Chemical class 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Emergency Medicine (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL10184846T 2004-05-12 2005-05-12 Triglicerydy, kwasy tłuszczowe i alkohole jako modulatory oun PL2316530T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US57013704P	2004-05-12	2004-05-12
GB0420856A GB0420856D0 (en)	2004-09-20	2004-09-20	Cns modulators
EP10184846.3A EP2316530B1 (en)	2004-05-12	2005-05-12	Triglycerides, fatty acids, alcohols as cns modulators
EP05742109.1A EP1755743B1 (en)	2004-05-12	2005-05-12	Beta hydroxybutyrate and derivatives for treating depression and anxiety

Publications (1)

Publication Number	Publication Date
PL2316530T3 true PL2316530T3 (pl)	2015-01-30

Family

ID=33306877

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL10184846T PL2316530T3 (pl)	2004-05-12	2005-05-12	Triglicerydy, kwasy tłuszczowe i alkohole jako modulatory oun
PL05742109T PL1755743T3 (pl)	2004-05-12	2005-05-12	Beta-hydroksymaślan i pochodne do leczenia depresji i lęku

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PL05742109T PL1755743T3 (pl)	2004-05-12	2005-05-12	Beta-hydroksymaślan i pochodne do leczenia depresji i lęku

Country Status (8)

Country	Link
US (3)	US20080058416A1 (pl)
EP (2)	EP2316530B1 (pl)
DK (2)	DK2316530T3 (pl)
ES (2)	ES2513890T3 (pl)
GB (1)	GB0420856D0 (pl)
PL (2)	PL2316530T3 (pl)
PT (1)	PT1755743E (pl)
WO (1)	WO2005107875A2 (pl)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0427145D0 (en) *	2004-12-10	2005-01-12	Ketocytonyx Inc	Compositions for use in surgery
CA2684213A1 (en)	2007-04-12	2008-10-23	Regents Of The University Of Minnesota	Ischemia/reperfusion protection compositions and methods of using
BR112015024186B1 (pt)	2013-03-19	2023-05-09	University Of South Florida	Composições e métodos para produção de cetose de elevação e manutenção
US10568854B2 (en)	2014-05-30	2020-02-25	The Johns Hopkins University	Compositions and methods for treating kabuki syndrome and related disorders
US10980764B1 (en)	2016-02-01	2021-04-20	University Of South Florida	Exogenous ketone supplements for reducing anxiety-related behavior
US11241403B2 (en)	2016-03-11	2022-02-08	Axcess Global Sciences, Llc	Beta-hydroxybutyrate mixed salt compositions and methods of use
US10736861B2 (en)	2016-03-11	2020-08-11	Axcess Global Sciences, Llc	Mixed salt compositions for producing elevated and sustained ketosis
US11103470B2 (en)	2017-11-22	2021-08-31	Axcess Global Sciences, Llc	Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US10973792B2 (en)	2019-02-13	2021-04-13	Axcess Global Sciences, Llc	Racemic beta-hydroxybutyrate mixed salt-acid compositions and methods of use
US10973786B2 (en)	2016-03-11	2021-04-13	Axcess Global Sciences, Llc	R-beta-hydroxybutyrate, S-beta-hydroxybutyrate, and RS-beta-hydroxybutyrate mixed salt compositions
US11185518B2 (en)	2017-12-19	2021-11-30	Axcess Global Sciences, Llc	S-beta-hydroxybutyrate compounds and compositions enriched with S-enantiomer
US12599579B2 (en)	2016-04-19	2026-04-14	Axcess Global Sciences, Llc	Compositions and compounds containing ketone bodies and/or ketone body precursors and one or more amino acids
US10925843B2 (en)	2018-04-18	2021-02-23	Axcess Global Sciences, Llc	Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate
US12622889B2 (en)	2016-04-19	2026-05-12	Axcess Global Sciences, Llc	S-β-hydroxybutyrate esters for improving metabolic function
US11944598B2 (en)	2017-12-19	2024-04-02	Axcess Global Sciences, Llc	Compositions containing s-beta-hydroxybutyrate or non-racemic mixtures enriched with the s-enatiomer
SG11201809211QA (en) *	2016-04-19	2018-11-29	Keto Patent Group Inc	Administration of butyrate, beta-hydroxybutyrate, and related compounds in humans
US12496283B2 (en)	2016-04-19	2025-12-16	Axcess Global Sciences, Llc	Administration of R-beta-hydroxybutyrate and related compounds in humans
US20230346721A1 (en)	2018-04-18	2023-11-02	Axcess Global Sciences, Llc	Beta-hydroxybutyric acid compositions and methods for delivery of ketone bodies
US11026929B2 (en)	2016-04-19	2021-06-08	Keto Patent Group, Inc.	Administration of berberine metabolites
US12521378B2 (en)	2016-04-19	2026-01-13	Axcess Global Sciences, Llc	Administration of R-beta-hydroxybutyrate salt blend and related compounds in humans
US12109182B2 (en)	2016-04-19	2024-10-08	Axcess Global Sciences, Llc	Administration of R-beta-hydroxybutyrate and related compounds in humans
US12329734B2 (en)	2017-12-19	2025-06-17	Axcess Global Sciences, Llc	Use of S-beta-hydroxybutyrate compounds for induction and maintenance of flow
US11202769B2 (en)	2017-11-22	2021-12-21	Axcess Global Sciences, Llc	Ketone body esters of s-beta-hydroxybutyrate and/or s-1,3-butanediol for modifying metabolic function
US12533346B2 (en)	2016-04-19	2026-01-27	Axcess Global Sciences, Llc	Administration of berberine metabolites
US11806324B2 (en)	2018-04-18	2023-11-07	Axcess Global Sciences, Llc	Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies
WO2018009208A1 (en) *	2016-07-08	2018-01-11	Cognate Nutritionals, Inc.	Nutritional mitiggation of the cns effects of traumatic brain injury
US20180057846A1 (en)	2016-08-30	2018-03-01	KetoneAid Inc.	Partially buffered free acid and/or ketone blend for rapid onset ketosis and metabolic therapy
US11760963B2 (en)	2017-08-23	2023-09-19	KetoneAid Inc.	Ketogenic beer and alcoholic beverage mixture containing non-racemic ethyl 3-hydroxybutyrate and/or 1,3 butanediol
US10307398B2 (en)	2016-09-20	2019-06-04	Regents Of The University Of Minnesota	Resuscitation composition and methods of making and using
AU2017347778A1 (en)	2016-10-24	2019-05-16	University Of South Florida	Delaying latency to seizure by combinations of ketone supplements
US20180177753A1 (en) *	2016-12-23	2018-06-28	Neuroenergy Ventures, Inc.	Glyceryl 3-hydroxybutyrates for migraine symptom management
US9925164B1 (en) *	2017-01-12	2018-03-27	Neuroenergy Ventures, Inc.	Glyceryl 3-hydroxybutyrates for traumatic brain injury
US10376528B2 (en)	2017-03-10	2019-08-13	Tecton Group, Llc	Composition comprising ketone body and nicotinamide adenine dinucleotide modulator and methyl donor
US12171735B2 (en)	2017-04-19	2024-12-24	Axcess Global Sciences, Llc	Administration of butyrate, beta-hydroxybutyrate, cannabidiol, and related compounds in humans
US12090129B2 (en)	2017-11-22	2024-09-17	Axcess Global Sciences, Llc	Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US11419836B2 (en)	2019-02-13	2022-08-23	Axcess Global Sciences, Llc	Racemic and near racemic beta-hydroxybutyrate mixed salt-acid compositions
US11241401B2 (en)	2020-02-06	2022-02-08	Axcess Global Sciences, Llc	Enantiomerically pure r-beta-hydroxybutyrate mixed salt-acid compositions
US11129802B2 (en)	2018-08-27	2021-09-28	Axcess Global Sciences, Llc	Compositions and methods for delivering cannabidiol and ketone bodies
US10980772B2 (en)	2018-08-27	2021-04-20	Axcess Global Sciences, Llc	Compositions and methods for delivering tetrahydrocannabinol and ketone bodies
US20200061023A1 (en) *	2018-08-27	2020-02-27	Axcess Global Sciences, Llc	Compositions and methods for delivering tetrahydrocannabinol and ketone bodies
US12472200B2 (en)	2019-05-15	2025-11-18	Axcess Global Sciences, Llc	Autobiotic compositions and method for promoting healthy gut microbiome
CN113710243A (zh) *	2019-05-30	2021-11-26	神经活力投资公司	甘油三(β-羟基丁酸酯)与神经元短暂性脑缺血发作
US11033553B2 (en)	2019-06-21	2021-06-15	Axcess Global Sciences, Llc	Non-vasoconstricting energy-promoting compositions containing ketone bodies
US11969430B1 (en)	2023-03-10	2024-04-30	Axcess Global Sciences, Llc	Compositions containing paraxanthine and beta-hydroxybutyrate or precursor for increasing neurological and physiological performance
US11950616B2 (en)	2019-06-21	2024-04-09	Axcess Global Sciences, Llc	Non-vasoconstricting energy-promoting compositions containing ketone bodies
US12167993B2 (en)	2019-06-21	2024-12-17	Axcess Global Sciences, Llc	Non-vasoconstricting energy-promoting compositions containing ketone bodies
WO2021195477A1 (en)	2020-03-27	2021-09-30	Ketoneaid, Inc.	Ketone ester as a therapeutic treatment of covid-19, long covid, and related viral infections
US12186297B2 (en)	2020-08-26	2025-01-07	Axcess Global Sciences, Llc	Compositions and methods for increasing lean-to-fat mass ratio
TWI804037B (zh) *	2021-11-02	2023-06-01	長庚醫療財團法人高雄長庚紀念醫院	生酮飲食之評估系統及其運作方法

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE637726A (pl) *	1962-09-26
GB1476624A (en) *	1973-05-30	1977-06-16	Cepbepe	Tranquiliser medicaments
US4363815A (en) *	1975-07-23	1982-12-14	Yu Ruey J	Alpha hydroxyacids, alpha ketoacids and their use in treating skin conditions
DE2733202A1 (de) *	1976-08-04	1978-02-09	Agroferm Ag	Verfahren zur herstellung der d(-)-3-hydroxybuttersaeure
US4067999A (en) *	1976-12-15	1978-01-10	Food Technology Products	Control of hemorrhagic enteritis in turkeys
US4234599A (en) *	1978-10-04	1980-11-18	Scott Eugene J Van	Treatment of skin keratoses with α-hydroxy acids and related compounds
US4346107A (en) *	1979-02-12	1982-08-24	Claudio Cavazza	Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism
US4351835A (en) *	1981-04-01	1982-09-28	Montefiore Hospital	Method for preventing body fat deposition in mammals
FR2521857B1 (fr) *	1982-02-23	1985-10-31	Solvay	Compositions pharmaceutiques contenant de l'acide 3-hydroxybutanoique ou un sel derive de cet acide et sels derives de l'acide 3-hydroxybutanoique et d'une base organique azotee
DE3229955A1 (de) *	1982-08-12	1984-02-16	Erichsen, Friedrich Karl, Dr., 2351 Schillsdorf	Arzneimittel mit analgetischer wirkung
US4701443A (en) *	1983-03-22	1987-10-20	Baxter Travenol Laboratories, Inc.	Nutrient polyesters
DE3581407D1 (de) *	1985-09-06	1991-02-21	Nestle Sa	Bewahrung lebender gewebe.
GB8525666D0 (en) *	1985-10-17	1985-11-20	Ici Plc	Chemical process
US5719119A (en) *	1985-12-18	1998-02-17	British Technology Group, Ltd.	Parenteral nutrition therapy with amino acids
JPS63502274A (ja) *	1985-12-18	1988-09-01	ビ−チ，リチヤ−ド　エル	Ｌ↓−乳酸および／またはピルビン酸アニオンを用いた流体式治療法
EP0258273A1 (en) *	1985-12-20	1988-03-09	VEECH, Richard L.	Preparation of electrolyte solutions and containers
US5126373A (en) *	1987-11-19	1992-06-30	Henri Brunengraber	Composition for parenteral and oral nutrition
US4997976A (en) *	1988-11-15	1991-03-05	Henri Brunengraber	Use of 1,3-butanediol acetoacetate in parenteral oral nutrition
US5292774A (en) *	1988-07-26	1994-03-08	Kanegafuchi Kagaku Kogyo Kabushiki Kaisha	Substitution fluid preparation comprising 3-hydroxy-butyric acid (β-hydroxybutric acid) and its salts
US5116868A (en) *	1989-05-03	1992-05-26	The Johns Hopkins University	Effective ophthalmic irrigation solution
US5286842A (en) *	1991-07-01	1994-02-15	Mitsubishi Kasei Corporation	Process for producing a biodegradable polymer
US5654266A (en) *	1992-02-10	1997-08-05	Chen; Chung-Ho	Composition for tissues to sustain viability and biological functions in surgery and storage
US5348979A (en) *	1992-12-23	1994-09-20	Iowa State University Research Foundation Inc.	Method of promoting nitrogen retention in humans
WO1995009144A1 (en) *	1993-09-30	1995-04-06	Eastman Chemical Company	Nutritive water soluble glycerol esters of hydroxy butyric acid
US5912269A (en) *	1996-04-30	1999-06-15	Vertex Pharmaceuticals, Inc.	Butyrate prodrugs derived from lactic acid
JP4598203B2 (ja) *	1995-12-01	2010-12-15	ビーティージー・インターナショナル・リミテッド	脳機能改善剤
JPH10158166A (ja) *	1996-12-02	1998-06-16	Taisho Pharmaceut Co Ltd	貼付剤
US6323237B1 (en) *	1997-03-17	2001-11-27	Btg International Limited	Therapeutic compositions
CN1315473C (zh) *	1997-03-17	2007-05-16	英国技术集团国际有限公司	治疗组合物
DE69903792T2 (de) *	1998-01-07	2003-08-14	Metabolix, Inc.	Tierfutterzusammensetzungen
JP4750232B2 (ja) *	1998-01-21	2011-08-17	フィドゥラン	ストレス、不安および攻撃性を低減するブタ鎮静フェロモン
CA2338090C (en) *	1998-07-22	2009-07-14	Metabolix, Inc.	Nutritional and therapeutic compositions of 3-hydroxyacids for increasing blood ketone bodies
CA2339941A1 (en) *	1998-09-15	2000-03-23	Btg International Limited	Use of cyclic esters of r-3-hydroxybutyrate for treatment of metabolic and neural degenerative disorders
US6835750B1 (en) *	2000-05-01	2004-12-28	Accera, Inc.	Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
ES2752800T3 (es) *	2000-05-01	2020-04-06	Cerecin Inc	Uso de triglicéridos de cadena media para el tratamiento y la prevención de la enfermedad del Parkinson resultante de un metabolismo neuronal reducido
WO2002062327A2 (en) *	2001-02-07	2002-08-15	Likhodi Serguei S	Method of treating neurological disorders using acetone derivatives
US20020132846A1 (en) *	2001-02-26	2002-09-19	Caleb Stone	Use of gamma substituted gamma-butyrolactones to increase levels of their corresponding substituted gamma-hydroxybutyrate derivatives in humans
US20040198819A1 (en) *	2001-06-20	2004-10-07	Young Aiping H.	Biological response modifier composition and uses thereof
US6579543B1 (en) *	2002-02-22	2003-06-17	Jackie H. McClung	Composition for topical application to skin
JP2003306430A (ja) *	2002-04-16	2003-10-28	Lion Corp	皮膚外用剤組成物
DK1648952T3 (en) *	2003-06-03	2018-05-28	The Us Gov As Represented By The Department Of Health And Human Services	Dietary supplements and therapeutic compositions comprising (R) -3-hydroxybutyrate derivatives
WO2005034874A2 (en) *	2003-10-08	2005-04-21	The Mclean Hospital Corporation	Enhanced efficacy of omega-3 fatty acid therapy in the treatment of psychiatric disorders and other indications
JP2007508315A (ja) *	2003-10-08	2007-04-05	ザマクレーンホスピタルコーポレーション	ω−３脂肪酸を含む組み合わせを用いて、精神障害、物質乱用障害、および他の障害を治療する方法

2004
- 2004-09-20 GB GB0420856A patent/GB0420856D0/en not_active Ceased
2005
- 2005-05-12 PT PT57421091T patent/PT1755743E/pt unknown
- 2005-05-12 EP EP10184846.3A patent/EP2316530B1/en not_active Expired - Lifetime
- 2005-05-12 DK DK10184846.3T patent/DK2316530T3/da active
- 2005-05-12 PL PL10184846T patent/PL2316530T3/pl unknown
- 2005-05-12 ES ES10184846.3T patent/ES2513890T3/es not_active Expired - Lifetime
- 2005-05-12 DK DK05742109.1T patent/DK1755743T3/da active
- 2005-05-12 PL PL05742109T patent/PL1755743T3/pl unknown
- 2005-05-12 US US11/596,012 patent/US20080058416A1/en not_active Abandoned
- 2005-05-12 EP EP05742109.1A patent/EP1755743B1/en not_active Expired - Lifetime
- 2005-05-12 WO PCT/GB2005/001835 patent/WO2005107875A2/en not_active Ceased
- 2005-05-12 ES ES05742109T patent/ES2410588T3/es not_active Expired - Lifetime
2014
- 2014-06-17 US US14/307,231 patent/US20140296337A1/en not_active Abandoned
2021
- 2021-12-08 US US17/643,237 patent/US20220202760A1/en not_active Abandoned

Also Published As

Publication number	Publication date
GB0420856D0 (en)	2004-10-20
ES2410588T3 (es)	2013-07-02
WO2005107875A2 (en)	2005-11-17
US20220202760A1 (en)	2022-06-30
US20140296337A1 (en)	2014-10-02
PL1755743T3 (pl)	2013-08-30
EP2316530A1 (en)	2011-05-04
US20080058416A1 (en)	2008-03-06
ES2513890T3 (es)	2014-10-27
WO2005107875A3 (en)	2006-03-23
EP2316530B1 (en)	2014-08-13
DK2316530T3 (da)	2014-11-03
EP1755743A2 (en)	2007-02-28
DK1755743T3 (da)	2013-06-10
EP1755743B1 (en)	2013-04-24
PT1755743E (pt)	2013-06-03

Publication	Publication Date	Title
DK2316530T3 (da)	2014-11-03	Triglycerider, fedtsyrer, alkoholer som cns-modulatorer
MX286464B (es)	2011-05-10	Formulaciones de acido graso omega 3.
AP2006003638A0 (en)	2006-06-30	Prostaglandin nitrooxyderivatives
AU2013260698A1 (en)	2013-12-12	Method for producing polyunsaturated fatty acids
IL190728A0 (en)	2008-11-03	Intravenous essential fatty acid emulsion
IL181330A0 (en)	2007-07-04	Thiazolo-naphthyl acids
SG126070A1 (en)	2006-10-30	Method of increasing the oxidation stability of biodiesel
ZA200807982B (en)	2009-11-25	Method for producing polyunsaturated fatty acids
PL1709143T3 (pl)	2013-02-28	Enzymatyczne modyfikowanie tłuszczów triglicerydowych
EP1958612A4 (en)	2012-12-26	TREHALOSE FATTY ACID ESTER COMPOSITION
PL1765318T3 (pl)	2015-02-27	Średniołańcuchowe kwasy tłuszczowe przydatne jako środki przeciwdrobnoustrojowe
GB2444896B (en)	2010-05-19	Compositions comprising polyunsaturated fatty acids
EP1934362A4 (en)	2011-12-28	ENZYMATIC OIL TESTERIFICATION
IL184193A0 (en)	2007-10-31	Processes for the preparation of aminoethoxybenzyl alcohols
GB0428384D0 (en)	2005-02-02	Eicosapentaenoic acid
EP1854893A4 (en)	2008-06-18	PROCESS FOR PRODUCING OPTICALLY ACTIVE SECONDARY ALCOHOL
ZA201002942B (en)	2011-07-27	Continuous method for the heterogenically catalyzed esterification of fatty acids
EP2092746A4 (en)	2012-05-09	DYNAMIC LAYOUTS
GB0402274D0 (en)	2004-03-10	Split nut
PT1894576E (pt)	2011-07-29	Novo agente redutor dos níveis de triglicéridos
GB0501060D0 (en)	2005-02-23	Microcapsule
PL1764210T3 (pl)	2016-06-30	Sposób sprasowania złomu
GB2442161B (en)	2008-05-21	Triglycerides
PL365353A1 (pl)	2005-08-22	Reaktor estrów olejowych
GB0606864D0 (en)	2006-05-17	Increades fatty acid oxidation